⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3523034 | 0.97 | — | — | |
| SCHEMBL4075630 | 0.82 | — | — | |
| SCHEMBL4555309 | 0.80 | — | — | |
| SCHEMBL19398814 | 0.78 | MMP1 (0.33) | — | |
| SCHEMBL18621827 | 0.78 | EPHX1 (0.56) | — | |
| SCHEMBL18560409 | 0.78 | EPHX1 (0.56) | — | |
| SCHEMBL12993988 | 0.78 | EPHX1 (0.56) | — | |
| SCHEMBL1273741 | 0.78 | MMP1 (0.40) | — | |
| SCHEMBL17641727 | 0.75 | — | — | |
| SCHEMBL4755259 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023166349-A2 | PHENYLUREA DERIVATIVE AND PHARMACEUTICAL USE THEREOF | 杭州百诚医药科技股份有限公司 | 2023-09-07 | — | — | WO | disclosed |
| WO-2023168367-A1 | QUINOLINE cGAS ANTAGONIST COMPOUNDS | IMMUNESENSOR THERAPEUTICS, INC. (US) | 2023-09-07 | — | — | WO | disclosed |
| WO-2023146512-A1 | COMPOUNDS AND METHODS OF USE THEREOF | VIVACE THERAPEUTICS, INC. (US) | 2023-08-03 | — | — | WO | disclosed |
| WO-2023146511-A1 | COMPOUNDS AND METHODS OF USE THEREOF | VIVACE THERAPEUTICS, INC. (US) | 2023-08-03 | — | — | WO | disclosed |
| WO-2023146513-A1 | COMPOUNDS AND METHODS OF USE THEREOF | VIVACE THERAPEUTICS, INC. (US) | 2023-08-03 | — | — | WO | disclosed |
| WO-2023066292-A1 | TRICYCLIC BORONIC ACID DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 上海济煜医药科技有限公司 | 2023-04-27 | — | — | WO | disclosed |
| WO-2022133069-A1 | PEPTIDOMIMETIC MATRIPTASE 2 INHIBITORS AND USES THEREOF | DISC MEDICINE, INC. (US) | 2022-06-23 | — | — | WO | disclosed |
| WO-2021239117-A1 | MODIFIED PROTEINS AND PROTEIN DEGRADERS | CULLGEN (SHANGHAI) , INC. (CN) | 2021-12-02 | — | — | WO | disclosed |
| WO-2021141789-A1 | STABLE FORMULATIONS OF ANTI-CANCER PEPTIDES | ONCOLYZE, INC. (US) | 2021-07-15 | — | — | WO | disclosed |
| WO-2021127452-A1 | COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION OF ANTIBIOTICS | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2021-06-24 | — | — | WO | disclosed |
| US-20090019645-A1 | UNKNOWN | L'OREAL S.A. (FR) | 2009-01-22 | — | — | US | disclosed |
| US-20080244838-A1 | Composition for the coloring of keratinous fibers comprising a halochromic compound and/or the dye corresponding to this compound, and method of use thereof | L'OREAL S.A. (FR) | 2008-10-09 | — | — | US | disclosed |
| US-20080235883-A1 | Composition for the coloring of keratinous fibers comprising a halochromic compound, the dye corresponding to this compound, and methods of use thereof | L'OREAL S.A. (FR) | 2008-10-02 | — | — | US | disclosed |
| US-7413746-B2 | Stent coatings containing self-assembled monolayers | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2008-08-19 | — | — | US | disclosed |
| US-20080189878-A1 | Dyeing process using a dye of styryl or imine type in combination with a weak acid, and device for implementing the process | L'OREAL S.A. (FR) | 2008-08-14 | — | — | US | disclosed |
| WO-2008042928-A2 | OXADIAZOLE AND THIADIAZOLE DERIVATIVES AS MITOTIC KINESIN INHIBITORS AND METHODS OF USE THEREOF | ARRAY BIOPHARMA, INC. (US) | 2008-04-10 | — | — | WO | disclosed |
| US-20070218246-A1 | Stent coatings containing self-assembled monolayers | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2007-09-20 | — | — | US | disclosed |
| US-20070037834-A1 | Anti-inflammatory; cellular infiltration inhibition modulating activity on thymus and activation-regulated chemokine and macrophage-derived chemokine functions; inhibitory activities against binding of TARC and MDC to T cells; allergic disease, autoimmune disease, transplant, graft rejection | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2007-02-15 | — | — | US | disclosed |
| US-5264448-A | Thioamides, oxazole ring, insecticides, miticides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-11-23 | — | — | US | disclosed |
| EP-0394043-A1 | An amide compound and its production and use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-10-24 | — | — | EP | disclosed |